Market News

Stay updated with the latest market trends, earnings, and economic indicators.

Showing news for:ALKEM
Clear all filters
NEWS
positive
Business Standard - Markets 4d ago

Alkem Laboratories Ltd gains for third consecutive session

Alkem Laboratories Ltd is quoting at Rs 5680, up 1.46% on the day as on 12:49 IST on the NSE. The stock is up 18.31% in last one year as compared to a 4.13% drop in NIFTY and a 16.41% drop in the Nifty Pharma index.

ALKEMAONELIQUIDAONENIFTYAONETMMQ50AONETOTALBANKIETFPHARMABEESPVTBANIETFFinancial ServicesHealthcare
Indian pharma firms gear up to supply key cancer drug to US
negative
ET Markets - Industry 17d ago

Indian pharma firms gear up to supply key cancer drug to US

Indian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading companies like Zydus, Cipla, Alkem, and Aurobindo Pharma are in discussions to supply the medicine. The US FDA has reached out to Indian pharmaceutical bodies, seeking manufacturers capable of producing the drug in various strengths to ensure availability for cancer patients.

ALKEMAUROPHARMACIPLAVITALChemicalsHealthcare
Cipla, Alkem, Zydus shares gain as US FDA reportedly approaches Indian firms for cancer drug supply - Upstox
neutral
Google News - India Markets 18d ago

Cipla, Alkem, Zydus shares gain as US FDA reportedly approaches Indian firms for cancer drug supply - Upstox

Cipla, Alkem, Zydus shares gain as US FDA reportedly approaches Indian firms for cancer drug supplyUpstox

ALKEMCIPLAHealthcare
Sun Pharma, Alkem Labs, other pharma stocks gain despite stock market crash; Nifty Pharma rises for fourth day in a row - Mint
positive
Google News - India Markets 33d ago

Sun Pharma, Alkem Labs, other pharma stocks gain despite stock market crash; Nifty Pharma rises for fourth day in a row - Mint

Sun Pharma, Alkem Labs, other pharma stocks gain despite stock market crash; Nifty Pharma rises for fourth day in a rowMint

ABSLBANETFABSLNN50ETABSLPSEALKEMAONETMMQ50AONETOTALBSLNIFTYHEALTHYMOCAPITALMOMENTUMNIFTYQLITYPHARMABEESSPARCTECHFinancial ServicesHealthcare
Alkem Labs shares in focus as Goldman, Morgan Stanley, others purchase stake in Rs 930-crore block deal
positive
ET Markets - Stocks 38d ago

Alkem Labs shares in focus as Goldman, Morgan Stanley, others purchase stake in Rs 930-crore block deal

Shares of Alkem Laboratories will be in focus after block deals worth around Rs 930 crore saw 17.88 lakh shares traded at Rs 5,200 apiece on Tuesday. Promoter-linked entities offloaded their stake, while domestic mutual funds and foreign institutional investors emerged as key buyers, signalling strong institutional participation. The company also launched semaglutide pre-filled syringes in India.

ALKEMALPHAETFEQUAL200FOCUSGOLD1GOLDBETAGROWWN200HDFCGOLDLICNETFSENMIDCAPBETAMOM30IETFMOMENTUMMOMENTUM30MOMOMENTUMNEXT50BETANIFTYQLITYSILVERBETASTANLEYTATAGOLDTATSILVTNIDETFConsumer DurablesFinancial Services
Stocks to Watch, June 3: Alkem Labs, Dhanuka Agritech, Paytm, Canara Bank
neutral
Business Standard - Markets 38d ago

Stocks to Watch, June 3: Alkem Labs, Dhanuka Agritech, Paytm, Canara Bank

Stocks to Watch today, June 3: Infosys, Alkem Labs, Paytm among others in focus; here's why

AGRITECHALKEMBANKINDIACANBKDHANUKAFOCUSINFYPAYTMChemicalsConsumer Durables
Stocks in news: Alkem Labs, Vedanta, Canara Bank, NHPC, Adani Ports
positive
ET Markets - Stocks 38d ago

Stocks in news: Alkem Labs, Vedanta, Canara Bank, NHPC, Adani Ports

Markets closed higher on weekly expiry day despite volatility, with Nifty showing signs of recovery but facing resistance around 23,800-24,000. Key stocks like Alkem Labs, Vedanta, Canara Bank, NHPC, and Adani Ports are in focus due to significant corporate developments including block deals, ED visits, capital raising plans, oversubscribed OFS, and strong cargo volumes.

ABSLBANETFADANIENTADANIPORTSAKCAPITALKEMALPL30IETFARIHANTCAPBANKADDBANKBEESBANKBETABANKBETFBANKETFBANKIETFBANKINDIABANKNIFTY1BANKPSUBBNPNBETFBNKETFAXISCANBKCAPITALSFBCPCAPEBANKNIFTYECAPINSUREFINIETFFOCUSGROWWCAPMGROWWLOVOLGROWWPSUBKHDFCNIFBANHDFCPSUBKHDFCPVTBANLOWVOLLOWVOL1LOWVOLIETFMOCAPITALNHPCNPBETPSUBANKPSUBANKADDPSUBNKBEESPSUBNKIETFPVTBANIETFPVTBANKADDSETFNIFBKVEDLConsumer DurablesFinancial Services
Alkem Labs sees Rs 930 crore block deal as promoter family entities pare stake; Goldman, Morgan Stanley among key buyers
positive
ET Markets - Stocks 38d ago

Alkem Labs sees Rs 930 crore block deal as promoter family entities pare stake; Goldman, Morgan Stanley among key buyers

Alkem Laboratories shares experienced significant block deals totaling Rs 930 crore. Promoter family entities divested shares to a group of domestic mutual funds and foreign institutional investors. This transaction occurred after a strong performance by Alkem Laboratories shares over the past year. The deal highlights continued institutional interest in the pharmaceutical sector.

ALKEMESGMOGSECMOSERVICESETF10GILTSTANLEYConsumer DurablesFinancial Services
NEWS
negative
Business Standard - Markets 38d ago

Alkem launches semaglutide in ready-to-use single-shot pre-filled syringes

Alkem is the first company in India to introduce semaglutide in single-shot pre-filled syringe format, expanding treatment options for patients and lowering entry barriers with its affordable pricing. The ready-to-use single shot pre-filled syringe format offers enhanced access, and convenience.

AFFORDABLEALKEMCapital GoodsHealthcare
Alkem launches India’s first ready-to-use semaglutide syringe for diabetes and weight loss from ₹350
neutral
CNBC TV18 - Markets 39d ago

Alkem launches India’s first ready-to-use semaglutide syringe for diabetes and weight loss from ₹350

The launch comes as India grapples with rising diabetes and obesity cases, offering patients another treatment option designed to improve long-term adherence.

ALKEMLTGILTBEESFinancial ServicesHealthcare
Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight loss
positive
ET Markets - Industry 39d ago

Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight loss

Alkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordable for diabetes and obesity management. The company is the first in India to offer this convenient format. This move intensifies competition in the growing Indian drug market. Alkem aims to expand access to quality medicines for better patient care.

AFFORDABLEALKEMAONETMMQ50Capital GoodsFinancial Services
Stocks to Watch, June 2: NHPC, Alkem Labs, Wipro, Paytm, Ola Electric
positive
Business Standard - Markets 39d ago

Stocks to Watch, June 2: NHPC, Alkem Labs, Wipro, Paytm, Ola Electric

Stocks to Watch, June 2: L&T, Anant Raj, Ola Electric, Paytm, Alkem Labs among shares to remain on investors' and traders' radar today

ALKEMANANTRAJNHPCOLAELECPAYTMWIPROAutomobile and Auto ComponentsFinancial Services
Next